Make every breath count.

PNOĒ, founded by Apostolos Atsalakis and Panos Papadiamantis, is a healhtech company based on human respiration, transforming the way we identify, track and understand biomarkers through breath analysis. The company's primary product is a non-invasive breath analysis solution, which measures biomarkers as indicators of users’ health condition, through a 12-minute test, aiming to improve their cardiopulmonary health, nutrition, and exercise. PNOĒ leverages the science behind cardio-metabolic analysis (CMA) which assesses the users’ health state, by measuring the concentration of carbon dioxide and oxygen in their breathing. PNOĒ’s almost fully-automated system of algorithms and experts translates users’ breathing into actionable, personalized insights, such as dietary improvements, in 24 hours or less. The company has established its presence internationally, in a market with significant, untapped potential, further supported by the paradigm shift in how we view our health as a result of the pandemic.

To date, the company is being used by over 2000 businesses, top-tier health professionals and trusted by professional athletes, including NBA players. PNOE is a Y Combinator graduate and has raised over $10 million, actively growing on a global scale, with presence across Europe, the US and Latin America. Their growth is further supported by the diversity of their customer base, spanning from sports teams to gyms and hotels, as well as the overarching application of the company's breath analysis solution.